Ian Karp | Vice President, Investor and Public Relations |
Dr. Michael Kauffman | Chief Executive Officer |
Perry Monaco | Senior Vice President, Sales |
Mike Mason | Chief Financial Officer |
Christopher Primiano | Chief Business Officer and General Counsel |
Brian Abrahams | RBC Capital Markets |
Arlinda Lee | Canaccord |
Jonathan Chang | SVB Leerink |
Mike Ulz | Baird |
Ed White | H.C. Wainwright |
Good morning. My name is Skyler and I will be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics Second Quarter 2019 Financial Results Conference Call. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company’s request.